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Wall shear stress (WSS), a tangential stress exerting on the inner surface of blood 
vessels is an important determinant of endothelial cell structure and function.  It is also 
one of the major stimuli for the release of vasoactive substance, nitric oxide (NO), which 
plays a critical role in the regulation of vascular diameter and maintenance of vascular 
resistance.  Abnormally low WSS is found to be associated with atherosclerosis whereas 
abnormally high WSS is correlated with aneurysm.  Therefore the study of WSS is of 
particular importance as any disruptions of WSS in microcirculation might lead to 
diseases. Red blood cell (RBC) aggregation and hematocrit (Hct) are the main 
hemorheological factors and contributors to the blood viscosity and vascular resistance.  
However, little quantitative information of RBC aggregation and Hct on WSS is available.  
The objectives of the project are to investigate effects of two hemorheological factors 
RBC aggregation and Hct, and a geometric factor, tube diameter (tube size) on WSS.  
The study was performed with special reference to the levels of RBC aggregation and Hct 
found in normal and diseases states in microtubes of inner diameter (ID) 30 µm, 50 µm 
and 100 µm relevant to microcirculation.  Non-aggregating medium of phosphate buffer 
saline (PBS), normal aggregating medium (Dextran 500-PBS solution of concentration 
7.5 mg/ml) and disease aggregating medium (Dextran 500-PBS solution of concentration 
12.5 mg/ml) were used in the study.  Blood samples at Hct level of 40% mimicking 
physiological conditions and Hct level of 20% and 60% mimicking clinical levels were 
utilized.  Relative WSS (WSS of blood suspension normalized by the WSS of suspending 
medium) was used to isolate the medium viscosity effect on the WSS.  
 vi
 The results showed that RBC aggregation was effective in reducing the WSS in low 
pseudoshear rates corresponding to venular flows, but insignificant in affecting WSS in 
high pseudoshear rates corresponding to arteriolar flows.  However, increased Hct and 
tube diameter led to significant elevations in WSS in most pseudoshear rates except at 
pseudoshear rate of about 3 s-1 corresponding to reduced venular flows.  At low 
pseudoshear rate of approximate 3 s-1, insignificance difference in WSS between Hct 
20% and 40% and between microtubes of ID 30 µm and 50 µm was found in aggregating 
mediums and this could likely be attributed to the enhanced cell-free layer formation.  
The results suggested that effects of RBC aggregation could likely be more dominant 
over effects of Hct and tube diameter in contributing to WSS at low pseudoshear rates 
whereas the effects of Hct and tube diameter might be more prominent at high 
pseudoshear rates.  
The comprehensive quantitative information on effects of RBC aggregation, Hct and 
tube diameter on WSS with special reference to normal and disease level of RBC 
aggregation and Hct obtained from the study would lead to an advanced understanding of 
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CHAPTER 1  INTRODUCTION 
 
1.1 Clinical significance of wall shear stress in microcirculation 
The microcirculation consists of blood vessels of diameter < 160 µm, mainly 
arterioles, venules and capillaries [1].  It is the site that contributes to and regulates the 
60-70% of total vascular resistance [2].  By vasoconstriction, arterioles ensures the 
pressure gradient steep enough for driving blood flow through the entire circulation [2, 3].  
On the other hand, vessels dilate in response to increased tissue perfusion, facilitating the 
exchange of nutrients and wastes between blood and tissues [4, 5].  The key path that 
microcirculation regulates the vascular resistance is via an important rheological 
parameter, wall shear stress (WSS).  WSS, a tangential stress exerting on the inner 
surface of blood vessels is an important determinant of endothelial cell structure and 
function [6, 7].  In addition, it is one of the major stimuli for the release of vasoactive 
substance, nitric oxide (NO), which plays a critical role in the regulation of vascular 
diameter and maintenance of flow resistance [8-10].  Moreover, WSS is an important 
parameter in providing clinical indications for many diseases including atherosclerosis, 
hemorrhage and aneurysm [4].  Atherosclerosis is often found in regions of abnormally 
low WSS [11-13].  Abnormally high WSS is found to be associated with aneurysm [14-
16].  Therefore the study of WSS is of particular importance as any disruptions of WSS 
in microcirculation might lead to diseases.  
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1.2 Motivation and objectives  
Red blood cell (RBC) aggregation and hematocrit (Hct) are the main hemorheological 
factors and contributors to the blood viscosity and flow resistance.  However, despite 
extensive studies of RBC aggregation and Hct on blood rheology, to our knowledge, little 
quantitative information of RBC aggregation and Hct on WSS is available.  Hence the 
objectives of the present study are to obtain such information with special reference to the 
levels of RBC aggregation and Hct found in normal and disease states in glass microtubes 
of inner diameter (ID) 30 µm, 50 µm and 100 µm relevant to microcirculation and are 
described as follow: 1) to investigate RBC aggregation effect on WSS; 2) to study the 
Hct effect on WSS; 3) to study the effect of tube diameter (tube size) on WSS.  Blood 
samples would flow through these microtubes over a wide range of pseudoshear rates 
found in arterioles and venules.  The quantitative information obtained from this study 
would be helpful for better understanding effects of RBC aggregation and Hct found in 
normal and disease level on WSS in vivo and this would be an important step in 
developing new therapeutic approaches to WSS related diseases. 
 
1.3 Outline of the dissertation 
Chapter 2 provides the background knowledge of two essential hemorheologic 
parameters, RBC aggregation and Hct and an important geometrical parameter, tube 
(vessel) diameter or tube size.  Chapter 3 reviews the WSS and methods of obtaining 
WSS.  Chapter 4 describes the materials and methods for the study.  Chapter 5 presents 
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the experimental results.  Chapter 6 provides discussion based on the results in Chapter 5.  























CHAPTER  2 LITERATURE REVIEW 
 
2.1 RBC aggregation 
 
2.1.1 Aggregation formation  
RBC aggregation is naturally present in human and athletic species such as horse and 
absent in non-athletic species [17].  RBCs form loose and reversible aggregates (also 
known as rouleaux) induced by large protein fibrinogens and globulins with characteristic 
face to face morphology, similar to a stack of coins at low shear rates [18] as shown in 
Fig. 1 [19].  Aggregation is reversible process and RBC aggregates disperse in a high 
shear environment [20].  Formation of RBC aggregation at low shear rates leads to an 
increase in the blood viscosity, contributing to the shear-thinning property of blood [21].  
Aggregation phenomenon can also be observed by the infusion of high molecular 
weight Dextran 500 into the suspending medium of RBC [22].  Currently bridging theory 
[23] and depletion theory [24, 25] have been proposed to account for the macromolecule-
mediated aggregation phenomenon.  The bridging model proposes that large proteins 
polymers like fibrinogens or large polymers like Dextran 500 behaves like bridging 
agents and can adsorb non- specifically onto the RBC membranes.  When two RBC 
membranes are attached and bridged by the bridging agents, RBC aggregates are formed 
[23].  The depletion model proposes that when a RBC membrane contacts with a polymer 
solution (eg.  Dextran 500 or fibrinogen), a “depletion layer” forms because the loss of 
configurational entropy of the polymer [25, 26],  resulting in a lower concentration of 

































build up between the bulk phase and the depletion layer.  This osmotic pressure 
difference drives the fluid in the depletion layer out and adjacent RBCs to approach each 
other and aggregates are formed [25, 26].   
 
2.1.2 Aggregation in diseases  
Elevated levels of RBC aggregation have been found in a wide variety of clinical 
conditions.  The RBC aggregation levels at stasis and low shear rate of 3 s-1 in sepsis 
patients were significantly higher than that in healthy people ( p < 0.001 ) [27].  A 
significant ( P = 0.002 ) elevation in the level of RBC aggregation was observed in the 
pregnancy-induced hypertension group compared with the controls [28].  RBC 
aggregation values at stasis and at low shear rate of 3 s-1 were statistically higher in 
myocardial infarction patients than in controls ( p = 0.007 and p = 0.001 ) respectively 
[29].  Both the formation rate of RBC aggregates and the cohesion of the aggregation 
network were significantly increased in diabetic patients than in controls ( p < 0.001 ) 
[30].  Blood from obese subjects was reported to have relatively larger aggregates than 
that from healthy donors [31].  Therefore, the present study investigates effects of RBC 
aggregation on WSS with special reference to non-aggregating condition, normal 
aggregating condition and disease (elevated) aggregating condition. 
 
2.2 Hematocrit (Hct) 
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2.2.1 Hct   
Hematocrit (Hct) is the ratio of the volume of red blood cells (RBCs) to the total 
blood volume.  Hct is well known to be a major rheological determinant of blood 
viscosity and flow resistance [32-34].  Pries and coworkers reported that Hct was 
exponentially related to viscosity [32].   
 
2.2.2 Hct in diseases 
Normal Hct levels in human blood range from 39-45% [35].  However, abnormal Hct 
levels are often found in clinical conditions [36-38].  Patients suffering from kidney 
failures has Hct level of 32% [39].  Low Hct level of about 24.8% and 28% are found in 
disease of anemia and plasma cell dyscrasia respectively [38].  On the other hand, 
elevated Hct level is associated with diabetes (Hct = 52%) [40], hypertension and stoke 
(Hct = 51%) [37].  In addition, polycythemia, a bone marrow disorder that produces 
excessive RBCs could lead to elevated Hct levels of 55-57.6% [38, 41].  Hence, the 
present study investigates effects of the important physiological parameter Hct on WSS 
with special reference to Hct at physiological level of 40% and clinical level of 20% 
which simulates the anemia condition and 60% which simulates the polycythemia disease.   
 
2.3 Cell-free layer  
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2.3.1 Cell-free layer formation 
One of the major hemodynamic features in microcirculation is the cell-free layer 
formation between RBC core and the endothelium in arterioles and venules [42-44] as 
shown in Fig. 2.  This phenomenon occurs probably due to two reasons.  Firstly as the 
size of RBC approaches blood vessel diameter in the microcirculation, the wall exclusion 
effect due to the finite size of the RBC results in a cell-free layer having the width of half 
cell diameter or less at the vessel wall [45].  Secondly, the shearing forces in the flow 
induce rolling “tank tread” motion of the RBC membrane, causing RBCs to migrate 
toward the flow axis [46-48], leading to axial migration [45].  Hct is found to be a major 
determinant of cell-free layer that an increase in Hct leads to the reduction of cell-free 
layer due to the increased collisions among RBCs and reduced degree of axial migration 
[47, 49].  Elevated level of RBC aggregation was reported to enhance the degree of cell-
free layer formation [50, 51]. 
 
2.3.2 Effects of cell-free layer  
While the cell-free layer maintains smooth flow in the microcirculation, it can pose as 
an oxygen diffusion barrier [49].  A number of in vitro and in vivo studies reported that 
as the cell-free layer forms, the velocity profile become blunted in the centre of the tube 
and steepened near the wall [47, 52].  However, the effects of cell-free layer on the flow 
resistance have been reported to be different in vitro and in vivo conditions.  In vitro 
studies show that the decrease in the blood viscosity near the tube wall (also known as 
local blood viscosity) outweighs the increased blood viscosity at the centre due to the 
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formation of larger RBC aggregates, resulting in the reduction of the overall blood 
viscosity and flow resistance [50, 53].  However, Soutani and coworkers reported that  
RBC aggregation induced by Dextran 70 resulted in the elevated microvascular resistance 
in isolated rabbit mesentery model although increased the cell-free layer thickness was 
also observed, a finding that would be expected to cause a reduction in hydrodynamic 






































2.4 Tube effect 
 
2.4.1 Fahraeus effect 
Fahraeus is the first to find that Hct of blood in a narrow tube of diameter < 300 µm is 
lower than the feed Hct [55].  It is likely due to the axial migration of RBCs to the central 
streams and the velocity difference between the fast moving cells at the centre and slower 
moving suspending medium [56].  The velocity ratio of the RBC to the suspending 
medium increases with decreasing diameter of vessel or the tube and decreasing Hct 
concentration [46].  Thus, the Fahraeus effect reduces the Hct in single microvessels and 
the effect is more prominent in reduced Hct [32] and in a smaller vessel [42, 57].  In 
addition, at microvascular bifurcations where arteriolar daughter vessels branches off the 
side of the parent vessel, the cell-free medium preferably enters the daughter vessel [3, 
47], resulting in lower Hct in the daughter vessel than the parent vessel.  This 
phenomenon is named as plasma skimming [58].  When the branching vessel diameter is 
close to RBC size, RBCs do not follow the streamlines of the plasma and are screened 
out at the bifurcations and this phenomenon is named the cell screening [3, 47].  Plasma 
skimming and cell screening result in the network Fahraeus effect, resulting in the further 
reduction in Hct in microvessels [47].  This could probably decrease functional capillary 
density, which is a measure of the number of capillaries with RBC flow in a defined 
tissue region [59]. 
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2.4.2 Fahraeus-Lindqvist effect 
The Fahraeus effect is related to the Fahraeus-Lindqvist effect, which states that the 
blood viscosity decreases with decreasing microvessel diameter [60].  It is accounted 
probably by two possible reasons.  Firstly, the reduced Hct in smaller vessels or tubes due 
to Fahraeus effect leads to a decrease in blood viscosity.  Secondly, the presence of cell-
free layer in microvessels or microtubes contributes to a lower blood viscosity than blood 



















CHAPTER 3  WALL SHEAR STRESS 
 
 
3.1 Wall shear stress and its physiological roles 
The entire vascular system is lined by a thin layer of cells known as endothelium.  
Wall shear stress (WSS), a tangential stress arisen from the flow of viscous blood 
exerting on endothelium plays an important role in vascular homeostasis in the 
microcirculation [1, 5, 61].  WSS is one the main factors of remodeling the morphology 
of endothelial cells.  Endothelial cells exposed to shear stress alter their shapes and 
become elongated and align themselves parallel to the direction of flow in study of in 
vitro [62-64] and in vivo [65, 66].  Figure 3 shows a typical micrograph of the alignment 
of endothelial cells exposed to shear stress [61].  The degree of the time course of the 
change was found to be dependent on the magnitude of the shear stress and the exposure 
time [67].  
Furthermore, endothelial cells have been shown to respond to changes in WSS and 
modulate their functions including permeability and gene expression.  Jo and coworkers 
reported that the permeability of bovine endothelial cells increased with increasing 
exposed shear stress and returned to normal ranges when the external shear stress was 
removed [68].  Noria found that shear stress on endothelium caused partial disassembly 
of adherens junctions, leading to the elevation of permeability of the endothelial 
monolayer [69].  Up to date, hundred of endothelial genes have been found to be 
regulated by WSS [70], such as nitric oxide (NO) synthases for synthesis of NO [71, 72], 




                            A                                                                             B 
 
Figure 3. Micrographs of the flow-induced alignment of cultured endothelial cells in vitro. 
A: the endothelial cells are cultured in static conditions; B: the endothelial cells have 
been exposed to laminar shear stress in the upward direction indicated by the arrow for 





















for the regulation of cell growth and migration [73, 74]. 
 
 
3.1.1 Roles of nitric oxide  
One of the most important genes regulated by WSS is endothelial isoform of NO 
synthase which catalyzes the production of a powerful vasodilator, NO by oxidation of L-
arginine inside the endothelial cells [75].  As shown in Fig. 4, an increase in 
microvascular flow velocity leads to an increased wall shear rate (WSR) and WSS when 
blood viscosity and vessel diameter are constant [76].  The increased local WSS 
stimulates NO synthase, which synthesizes the vessel dilating agent NO.  The NO is then 
secreted by endothelial cells and reaches the smooth muscle cells via diffusion through 
myoendothelial junctions, leading to the relaxation of smooth muscle cells and local 
vasodilations [77].  The increase in vessel diameter facilities the blood flow and causes 
partial return of the WSS.  In addition, NO also contributes to vascular homeostasis by 
inhibiting platelet aggregation [78], leukocyte adhesion to the endothelium [75] and 
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Figure 4. Schematic diagrams of flow-induced dilation showing changes of WSS that 









3.2 Pathophysiological effects of abnormal WSS 
A number of studies have reported that abnormally low WSS was associated with the 
development and progression of atherosclerosis [11-13].  This phenomenon could be 
probably attributed to that persisting low WSS attenuates production of atheroprotective 
NO, promoteing local lipid uptake and accumulation [81], inflammation [82], oxidative 
stress [83, 84], extracellular matrix degradation [85, 86] and plaque calcification [80, 87-
89].  Low WSS also downregulates prostacyclin, another endothelial vasodilatory 
substance [11, 72] while upregulating endothelin, a potent vasoconstrictive agent [90, 91].  
The resulting unwanted vascular constriction could lead to high blood pressure [92, 93].   
Abnormally elevated WSS has been reported to cause endothelial disruptions and 
injuries, promoting intimal diseases [94-96].  One of the diseases caused by overloaded 
WSS was aneurysm [14-16].  Fukuda and coworkers found that the overproduction of 
NO induced by elevated WSS favored the development of aneurysm [15].  In vivo studies 
reported that the increased WSS led to the decrease in smooth muscle proliferation [97, 
98].  However, fewer smooth muscle cells and more irregular layers of collagen were 
often found in ruptured aneurysms [99], suggesting that overloaded WSS might increase 
the risk of the aneurysm rupture.   
 
3.3 Methods of measuring WSS 
WSS can be obtained by the product of wall shear rate (WSR) and local blood 
viscosity (blood viscosity near the wall).  WSR is defined as the radial derivative of blood 
velocity (also know as velocity gradient) at the wall.  
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3.3.1 Estimation of WSR 
The most widespread method for estimating WSR in vitro or in vivo relies on the 
assumptions of Newtonian property of blood and Poiseullie flow in the microtube or 
microvessel.  The assumptions lead to the parabolic velocity profile and the WSR as 
WSR = 8 ( V / D ) where V is the mean velocity and D is the tube or vessel diameter [100, 
101].  The mean velocity can be calculated from centreline RBC velocity using an 
empirical correction factor of 1.6 or 1.3 [101].  However, blood exhibits shear thinning 
property and velocity profile has been reported to deviate from parabolic profile in 
aggregating conditions especially at low flow rates.  The method may tend to 
underestimate the actual WSR.   
A more precise method for determining WSR is through assessment of the velocity 
profiles.  In this approach, fluoresce particles such as labeled platelets [102] and recent 
nanoparticles [103] are used as velocity tracers to determine the velocity measurement at 
discrete points across the cross-sectional areas.  However, due to the finite size of the 
labeled particles, no data point could be obtained closer to the wall than 0.2 µm [103].  
The estimation of the WSR depends on interpolation algorithm used to construct the 
velocity profile based on the available discrete velocity data [12].  Various algorithms 
such as linear extrapolation, linear extrapolation with correction for wall position, and 
quadratic extrapolation were applied to estimate the WSR, but none of them was error-
free [12, 104].  
Recently, Namgung and coworkers assumed that the velocity gradient in the cell-free 
layer was linear and estimated the WSR as WSR = Vedge/W where Vedge is the mean edge 
velocity of RBC core and W is the cell-free layer width [105].  However, the method may 
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underestimate the actual WSR since shear rate at the wall might be higher than that near 
the edge of RBC core.  
 
3.3.2 Estimation of local blood viscosity 
Whole blood viscosity or plasma viscosity were used as the estimated blood viscosity 
near the wall in the calculation [1, 6, 100].  However, the actual viscosity near the tube or 
vessel wall might be lower than whole blood viscosity measured in viscometer due to the 
presence of cell-free layer as discussed above, but higher than the plasma viscosity 
because of the protrusion of RBCs into the cell-free layer and the resulting extra energy 



















CHAPTER 4  MATERIALS AND METHODS 
 
4.1 Blood preparations and microtubes 
Horse whole blood (Innovative Research, Novi, USA) was first centrifuged (Sigma 2-
6, Goettingen, Germany) and washed with phosphate buffer saline (PBS) and the buffy 
coat consisting of leukocytes and platelets was removed.  At normal Hct of 40%, RBC 
aggregation index (M) was 0.0 (no aggregation) when RBCs were suspended in PBS 
medium, but elevated to 15.7 ± 0.9 corresponding to healthy aggregation level [106, 107] 
and 22.4 ± 0.7 corresponding to disease aggregation level [108] when RBCs were 
suspended in Dextran 500-PBS solution of concentration 7.5 mg/ml and 12.5 mg/ml 
respectively.  Hence PBS medium, 7.5 mg/ml and 12.5 mg/ml of Dextran 500-PBS 
solution were named as non-aggregating medium, normal aggregating medium (normal 
medium) and disease aggregating medium (disease medium) respectively in the present 
study.  The RBC aggregation index was determined with an aggregometer (Myrenne 
Aggregometer MA1, Roentgen, Germany) based on the 10-s setting.  Blood samples 
were adjusted to and verified to be at Hct of 20%, 40% and 60% with a microhematocrit 
centrifuge (Sigma 1-14, Goettingen, Germany).  The details of performing the 
aggregoemter and microhematocrit centrifuge were described in the previous study [109]. 
In the study of RBC aggregation effect on WSS, blood samples prepared with PBS 
medium, normal medium and disease medium at normal Hct of 40% were flowed in glass 
microtubes (Polymicro Technologies, Phoenix, USA) of inner diameter (ID) 50µm.  
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In the study of tube diameter effect on WSS, blood samples prepared with PBS 
medium, normal medium and disease medium at normal Hct of 40% were flowed in glass 
microtubes of ID 30 µm, 50 µm and 100µm.  
In the study of Hct effect on WSS, blood samples were prepared at normal Hct of 
40% and disease Hct levels of 20% and 60%.  The same three suspending mediums 
corresponding to non-aggregating blood, normal aggregating blood and disease 
aggregating blood and the microtubes of ID 30 µm, 50 µm and 100µm were employed to 
study the role of medium and tube diameter on the Hct effect on WSS.   
 
4.2 Perfusion system  
As shown in Fig. 5, the blood sample at targeted Hct level stored in a 1 ml syringe 
flowed through the microtube via an inner-lok (Polymicro Technologies, Phoenix, USA) 
under the required flow rate controlled by a syringe pump (KDS 210, Holliston, USA).  A 
pressure transducer (Biopac TSD 104A, Goleta, USA) that connected to a 1 ml syringe 
and an inner-lok was to measure the pressure difference across the glass microtube.  The 
pressure reading was only recorded upon reaching the steady state.  The bottom opening 
of glass microtube was submerged partially in the water of the beaker which acted as a 
reservoir to prevent capillary pressure.   
 
4.3 Experimental Procedure 
The system was first perfused with distilled water, which has a constant viscosity µ of 













TBDe /=μ                                                                                                                           (1) 
where µ is the water viscosity, T is the experimental temperature in Kelvin scale, D and B 
are 9.93×10-4 mPas and 2026.57 K respectively in a temperature range of 20 to 30 oC. 
The capillary tube was then calibrated using the distilled water and the exact ID of the 
capillary tube was found.  The exact ID were 29.1-31.8 µm, 48.9-52.5 µm and 98.7-102.5 
µm for microtubes of ID 30 µm, 50 µm and 100 µm respectively.  The length of 
microtubes was measured by vernier caliper and ranged between 49.5 and 50.5 mm.  The 
ratio of length to ID was over 400:1 so that pressure drop in other parts of the system 
could be negligible. 
The vertical set-up was first flushed with plasma to line the internal surface of the 
microtubes so as to prevent adhesion of RBCs to the internal surface, and then filled with 
the blood sample.  Magnetic stirrers were added to the syringe and stirred constantly 
throughout the experiment to prevent sedimentation of RBCs.  It was also imperative to 
ensure no bubbles were present in the setup throughout the experiment as compression of 
air in the bubbles would lead to inaccurate and delayed pressure readings.  If air bubbles 
were apparent in a part of the perfusion system, we disconnected the part that contained 
the bubbles, removed the bubbles, and reconnected the part back to the system.  We also 
checked the pressure variations over time to ensure no distinct pressure variations due to 
the invisible air bubble presence.  
A wide range of pseudoshear rates ranging from approximate 1 to 300 s-1 was 
achieved by adjusting the flow rate using the syringe pump.  The corresponding pressure 
was then recorded.   
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4.4 WSS calculation  
In the present study, WSS was calculated based on the static equilibrium between 
pressure and shear force.  The method worked well with both Newtonian and non-
Newtonian fluid and avoided possible errors arisen from the estimation of the WSR and 
local blood viscosity as discussed in Section 3.3.  Applying the Navier-Stokes equation 
and considering fully developed flow in a cylindrical vessel, WSS, τw  is expressed as 




Δ=τ                                                                                                              (2) 
where ∆P is pressure difference across the microtube, R is the radius of glass microtube 
and L is the length of the microtube. 
Pseudoshear rate γ, defined as the ratio of the average velocity in the microtube to the 
diameter of the micotube is given by the following equation: 
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Q
πγ =                                                                                                             (3)                               
where Q is the flow rate.   
In order to isolate the medium viscosity effect on the WSS, relative WSS (WSS of blood 
suspension normalized by the WSS of suspending medium), WSSrel was used to 




WSS exp=                                                                                                            (4) 
where WSSexp is the WSS obtained from the experiment and WSSmed is the shear stress 
exerted on the tube wall by the medium alone (in the absence of the RBCs) and could be 
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expressed as the follows based on the Newtonian property of the medium and the Hagen- 
Poiseuille’s law: 
medmedWSS μγ ××= 8                                                                                                      (5) 
where µmed is the medium viscosity.   
 
4.5 Statistical analysis 
One-way ANOVA (analysis of variance) test and post Bonferroni test were used to 
compare the means of the relative WSS in non-aggregating medium, normal aggregating 
medium and disease aggregating medium in tube of ID 50µm to examine the aggregating 
effect on WSS.  The same statistical test was used to compare the means of the relative 
WSS in microtubes of ID 30 µm, 50 µm and 100 µm when aggregating medium were 
kept constant to examine the tube diameter effect on WSS.  The same statistical test was 
also used to compare the means of relative WSS between Hct level of 20%, 40% and 
60% when aggregating mediums and tube diameters were kept constant to examine the 
Hct effect on WSS.  A commercial software package (Prism 5.0, Graphpad) was used for 
the above statistical analysis.  All data was reported as mean ± SD (standard deviation) 





CHAPTER 5  RESULTS 
 
Our WSS results of normal aggregating blood at normal arteriolar pseudoshear rate of 
approximate 200 s-1 were 2.95 ± 0.15 Pa, 3.91 ± 0.32 Pa and 5.55 ± 0.59 Pa in microtubes 
of ID 30 µm, 50 µm and 100 µm respectively, which agreed well with the arteriolar shear 
stresses of 4.71 ± 2.34 Pa in vessels of diameter < 100 µm in the cat mesenteric bed [111].  
The WSS at normal venular pseudoshear rate of 10 s-1 were 0.18 ± 0.01 Pa, 0.28 ± 0.02 
Pa, 0.49 ± 0.05 Pa in microtubes of ID 30 µm, 50 µm and 100 µm respectively which 
accorded with the values reported in venules of cat mesentery approximately ranging 
from 0.1 to 0.6 Pa [112].   
Dextran 500 was used in the alteration of RBC aggregation in the study.  However, it 
was also noted that addition of Dextran also changed the medium viscosity.  The 
suspending medium viscosity of non-aggregating medium, normal aggregating medium 
and disease aggregating medium were 1.00 ± 0.02 cp, 1.35 ± 0.01 cp and 1.65 ± 0.02 cp 
respectively.  Thus in order to isolate the medium viscosity effect on the WSS,  relative 
WSS (WSS of blood suspension normalized by the WSS of suspending medium) was 
used and presented in the following sections so as to investigate the effects of RBC 
aggregation, tube diameter and Hct on WSS.  
 




 Figure 6. Relative WSS of blood samples at 40% Hct over pseudoshear rates in 
microtube of ID 50 µm in non-aggregating blood suspended in PBS (○), normal 










Figure 6 showed Relative WSS of blood samples at 40% Hct over pseudoshear rates 
ranging from approximately 1 to 300 s-1 on a semi-logarithmic scale in a microtube of ID 
50 µm in non-aggregating blood, normal aggregating blood and disease aggregating 
blood.  The relative WSS curve for non-aggregating blood suspended in PBS increases 
with decreasing pseudoshear rate, similar to the shear thinning behavior of blood.  
However, it is noted that relative WSS curves of the aggregating blood behaved different 
from that of non-aggregating blood.  Initially, the decrease in the pseudoshear rate of 
about 300 s-1 led to an elevation of relative WSS.  However, upon reaching a particular 
pseudoshear rate, the trend was reversed and characterized by the reduction of the relative 
WSS with decreasing pseudoshear rates.  The particular pseudoshear rate at which the 
turning point occurs was named the threshold pseudoshear rate in this study.  The 
threshold pseudoshear rates were approximate 6 s-1 and 20 s-1 in the normal and disease 
level of RBC aggregation as shown in Fig. 6.  
In order to examine the aggregation effect on relative WSS, comparison of relative 
WSS in non-aggregating, normal and disease aggregating blood in microtube of ID 50 
µm at four typical pseudoshear rates of about 200 s-1, 80 s-1, 10 s-1 and 3 s-1 corresponding 
to the normal arteriolar pseudoshear rates of 187.9 ± 52.5 s-1 in rat cremaster muscles 
[105], reduced arteriolar pseudoshear rates of 76.7 ± 31.9 s-1 in rat cremaster muscles 
[113], normal venular pseudoshear rates in the range of 5 to 23 s−1 in cat sartorius muscle 
[5] and reduced venular pseudoshear rates < 5 s-1 in rat spinotrapezius muscle [114] 
respectively was made with one-way ANOVA test and post Bonferroni test and the 
results were shown in Fig. 7.  Figure 7 shows that at arteriolar pseudoshear rates of 





















Figure 7. Comparison of relative WSS of blood samples at 40% Hct in microtube of ID 
50 µm in non-aggregating blood suspended in PBS (open bar), normal aggregating blood 
(half filled bar) and disease aggregating blood (solid bar) at four typical pseudoshear 
rates. A): at pseudoshear rate of about 200 s-1 (simulating normal arteriolar flow); B) at 
pseudoshear rate of about 80 s-1 (simulating reduced arteriolar flow); C) at pseudoshear 
rate of about 10 s-1 (simulating normal venular flow); D) at pseudoshear rate of about 3 s-
1 (simulating reduced venular flow).  Values are means ± SD. * P < 0.05. ** P < 0.01. 






RBC aggregation did not differ significantly from each other.  Fig. 7C shows that at 
pseudoshear rate of about 10 s-1 relative WSS in disease aggregating blood (2.15 ± 0.23) 
was significantly lower than that in normal aggregating blood (2.59 ± 0.19, P < 0.05) and 
that in non-aggregating blood (2.60 ± 0.20, P < 0.05).  It was noted that there was no 
significant difference in relative WSS between non-aggregating blood and normal 
aggregating blood.  Fig. 7D showed that at pseudoshear rate of about 3 s-1, relative WSS 
of non-aggregating blood (3.40 ± 0.19) was significantly higher than that in normal 
aggregating blood (1.99 ± 0.13 Pa, P < 0.001) and disease aggregating blood (1.74 ± 0.12 
Pa, P <0.001), but relative WSS of disease aggregating blood did not differ from that in 
normal aggregating blood significantly.  
 
5.2 Tube effect on relative WSS 
The effect of tube diameter on relative WSS was studied with microtubes of ID 30, 50 
and 100 µm at normal Hct of 40% in the same three aggregating mediums as the Section 
5.1.  Figure 8 shows the relative WSS in the three microtubes over a wide range of 
pseudoshear rates from approximate 1 to 300 s-1 on a semi-logarithmic scale in non-
aggregating blood, normal aggregating blood and disease aggregating blood respectively.  
The results generally indicated that relative WSS increased with increasing tube diameter 
except at low pseudoshear rates < 6 s-1 in the aggregating mediums.  
Figure 9 shows the comparison of relative WSS between microtubes of ID 30 µm, 50 
µm and 100 µm at 40% Hct in the normal aggregating blood based on the same four 
particular pseudoshear rates as in Section 5.1.  Figure 9A shows that at normal arteriolar 
pseudoshear rate of approximate 200 s-1, the relative WSS increased significantly from 
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1.37 ± 0.02 in microtube of ID 30 µm to 1.82 ± 0.15 in microtube of ID 50 µm (P <0.05) 
and 2.59 ± 0.27 in microtube of ID 100 µm (P <0.001).  There was a significant 
difference (P <0.001) in relative WSS in microtube of ID 50 µm (1.82 ± 0.15) and in 
microtube of ID 100 µm (2.59 ± 0.27).  At the other pseudoshear rates as shown in Fig. 
9B, 9C and 9D, similar comparison results were shown such that relative WSS in 
different sized tubes differed from each other in the normal aggregating medium.  The 
comparison of relative WSS in non-aggregating medium and disease aggregating medium 
were also performed and shown in Fig. B1 and B2 in the Appendix B respectively and 
the overall results were summarized in Table 1.  The overall results showed that relative 
WSS in different sized tubes differed from each other significantly except at the reduced 














Figure 8. Relative WSS of blood samples at 40% Hct over pseudoshear rates in 
microtubes of ID 30 µm (○), 50 µm (∆) and 100 µm (□) in three aggregating mediums. 
(A): in non-aggregating blood suspended in PBS; (B): in normal aggregating blood; (C): 
















































Figure 9. Comparison of relative WSS of blood samples at 40% Hct in microtubes of ID 
30 µm, 50 µm and 100 µm in normal aggregating blood. (A): at pseudoshear rate of about 
200 s-1; (B) at pseudoshear rate of about 80 s-1; (C) at pseudoshear rate of about 10 s-1; 
(D) at pseudoshear rate of about 3 s-1.  Values are means ± SD.  * P < 0.05.  ** P < 0.01.  








Table 1.  Comparison of relative WSS of blood samples at 40% Hct between microtubes 
of ID 30 µm, 50 µm and 100 µm in three aggregating mediums based on four 






Medium & γ 
 
30 µm VS 50  µm 30  µm VS 100  µm 50  µm VS 100  µm
PBS  200 s-1  *** *** *** 
PBS  80 s-1  ** *** *** 
PBS  10 s-1  * *** *** 
PBS  3 s-1  * *** *** 
Normal  200 s-1  * *** *** 
Normal  80 s-1  * *** *** 
Normal  10 s-1  ** *** *** 
Normal  3 s-1  * *** *** 
Disease  200 s-1  * *** *** 
Disease  80 s-1  * *** *** 
Disease  10 s-1  * *** *** 
Disease  3 s-1  ns *** *** 
* P < 0.05.  ** P < 0.01.  *** P < 0.001.  ns = not significant.  PBS = PBS medium.  







5.3 Hct effect on relative WSS 
Figures 10A, 10B and 10C show the relative WSS at Hct of 20 %, 40 % and 60% 
over the same range of pseudoshear rates as in Section 5.1 and 5.2 in microtubes of ID 50 
µm in non-aggregating medium, normal aggregating medium and disease aggregating 
medium respectively.  The relative WSS results increased with increasing Hct level from 
20 % to 60% except at low pseudoshear rates < 10 s-1 in the aggregating medium.  The 
threshold pseudoshear rates as defined in section 5.1 were not observed in non-
aggregating blood, but were shown to begin at a higher pseudoshear rate for lower Hct 
blood in the aggregating blood.  The similar results were observed in microtubes of ID 30 
µm and 100 µm too and shown in Fig. B3 and B4 in the Appendix B.  The threshold 
pseudoshear rates for the three microtube of ID 30µm, 50 µm 100 µm in the three 
aggregating mediums were given in Table 2.  The results showed that the threshold 
pseudoshear rate did not occur in non-aggregating medium.  In the aggregating medium, 
the threshold pseudoshear rate increased with decreased Hct, decreased tube diameter and 









Figure 10. Relative WSS of blood samples at Hct of 20% (○), 40% (∆) and 60% (□) over 
pseudoshear rates in microtube of ID 50 µm in three aggregating mediums. (A): in non-
aggregating medium; (B): in normal aggregating medium; (C): in disease aggregating 

















Table 2. Threshold pseudoshear rates (s-1) for blood samples at Hct of 20%, 40% and 
60% in microtubes of ID 30 µm, 50 µm and 100 µm in three aggregating mediums 
 
  20% Hct 40% Hct 60% Hct 
30, 50 and100 µm,  PBS  NA NA NA 
30 µm, Normal  28 20 6 
50 µm, Normal  20 6 3 
100 µm, Normal  10 3 NA 
30 µm,  Disease  28 28 10 
50 µm,  Disease  20 20 6 
100 µm, Disease  10 6 3 
 




























In order to examine the Hct effect on relative WSS, comparison of relative WSS of 
20% VS 40% VS 60% was performed based on the same four typical pseudoshear rates 
as in section 5.1 and 5.2.  Figure 11 showed that the relative WSS at 20% Hct was 
significantly lower than that at 60% Hct in three aggregating mediums in microtube of ID 
50 µm.  Moreover, as shown in Fig. 11A and 11B, the relative WSS in PBS medium and 
normal medium at clinical Hct level of 20% and 60% differed significantly from that at 
normal Hct level of 40% in all compared pseudoshear rates of 200 s-1, 80 s-1, 10 s-1 and 3 
s-1.  However, there was no significant difference in relative WSS between 20% and 40% 
Hct (P > 0.05) at the lowest pseudoshear rate 3 s-1 in the disease medium.  The same 
comparisons in microtubes of ID 30 um and 100 um were also performed as shown in Fig. 
B5 and B6 in Appendix B and the overall results were summarized in Table 3.  The 
results showed that the high Hct of 60% led WSS to deviate significantly from that in 
healthy Hct level of 40% and clinical Hct level of 20%, indicating high Hct observed in 
disease such as polycythemia is likely to cause the significant elevation of WSS in 
arterioles and venules.  The relative WSS at low Hct of 20% differed significantly from 
that at healthy 40% Hct except at the reduced venular pseudoshear rate 3 s-1 in microtube 





















Figure 11. Comparison of relative WSS of blood samples at Hct level of 20% VS 40% 
VS 60% in microtube of ID 50 µm at four typical pseudoshear rates observed in normal 
arteriolar flow (200 s-1)  , reduced arteriolar flow (80 s-1), normal venular flow (10 s-1)  
and reduced venular flow (3 s-1) in three aggregating mediums. (A): in non-aggregating 
medium; (B): in normal medium; (C): in disease medium. Values are means ± SD. * P < 


















Table 3. Comparison of relative WSS between blood samples at Hct level of  20% VS 
40% VS 60% in three aggregating mediums in three microtubes of ID 30 µm, 50 µm and 











































 PBS medium Normal medium 


















100 μm  200 s-1 *** *** *** *** *** *** 
100 μm  80 s-1 * *** *** *** *** *** 
100 μm  10 s-1 *** *** *** *** *** *** 
100 μm  3 s-1 *** *** *** *** ** *** 
50 μm  200 s-1 *** *** *** ** *** *** 
50 μm  80 s-1 * *** *** ** *** *** 
50 μm  10 s-1 ** *** *** * *** *** 
50 μm  3 s-1 *** *** *** * *** *** 
30 μm  200 s-1 * *** *** *** *** *** 
30 μm  80 s-1 * *** *** * *** *** 
30 μm  10 s-1 *** *** *** * *** *** 
30 μm  3 s-1 *** *** *** ns *** *** 
   
Disease medium 
   
   










20    
100 μm  200 s-1 *** *** ***    
100 μm  80 s-1 ** *** ***    
100 μm  10 s-1 *** *** ***    
100 μm  3 s-1 *** *** ***    
50 μm  200 s-1 ** *** ***    
50 μm  80 s-1 * *** ***    
50 μm  10 s-1 * *** ***    
50 μm  3 s-1 ns *** ***    
30 μm  200 s-1 ** *** ***    
30 μm  80 s-1 ** *** ***    
30 μm  10 s-1 * *** ***    
30 μm  3 s-1 ns *** ***    
* P < 0.05.  ** P < 0.01.  *** P < 0.001. ns = not significant.  
20 VS 40 = Hct 20% VS 40%  
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CHAPTER 6  DISCUSSIONS 
 
To the best of our knowledge, this is the first study to obtain the compressive 
quantitative information on effects of important physiological parameters, RBC 
aggregation and Hct and one geometric factor, tube diameter (tube size) on the WSS in 
microtubes of ID 30 µm, 50 µm and 100 µm relevant to microcirculation.  Three 
suspending mediums associated with the RBC aggregation level found in non-athletic 
species, physiological human blood and pathological human blood were employed to 
study the aggregation effect on the WSS.  Blood samples at Hct level of 40% mimicking 
physiological conditions and Hct level of 20% and 60% mimicking clinical levels were 
used to study the Hct effect on WSS.  Relative WSS was used and analyzed since it could 
isolate the medium effect.  
 
6.1 Aggregation effect on WSS 
The present study showed that RBC aggregation was inadequate in affecting WSS in 
high arteriolar pseudoshear rates, but led to significant reduction in WSS at low venular 
pseudoshear rates and this effect was more prominent in disease aggregating states.  
At normal arteriolar and reduced arteriolar pseudoshear rates of around 200 s-1 and 80 
s-1, the aggregation of RBCs does not play an important role since the high shear flow 
disperses the aggregates [20, 53].  The high pseudoshear rates might also make the Hct 
distribution uniform and the velocity profile parabolic, causing the blood to behave like a 
Newtonian fluid.  As a result, WSR in blood suspension could approximate to the WSR 
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in medium only, and thus relative WSS could be similar to the relative blood viscosity 
which would be constant at the fixed Hct and shear rate based on the Weaver’s model 
[115].  
At normal venular pseudoshear rate of around 10 s-1, RBC aggregation could be likely 
to be present since pronounced sized RBC aggregates were observed at pseudoshear rates 
< 40 s-1 [116].  However, at this pseudoshear rate the degree of cell-free layer formation 
in disease aggregating blood could be more prominent than that in normal aggregating 
blood.  Thus the marked viscosity reduction effect due to the enhanced cell-free layer 
formation in disease aggregating blood might account for the significant lower relative 
WSS in disease aggregating blood compared to that in non-aggregating blood and normal 
aggregating blood as shown in Fig. 7C.  It was also worth noting that there was no 
significant difference in relative WSS between non-aggregating blood and normal 
aggregating blood probably due to that the phase separation of the RBCs and normal 
aggregating medium was not prominent at such pseudoshear rate. 
At reduced venular pseudoshear rate of approximately 3 s-1, the tendency of RBC 
aggregation increases further, probably resulting in the marked phase separation between 
the RBCs and suspending medium.  As a consequence, the reduction of local viscosity 
due to cell-free layer could become prominent in both normal aggregating blood and 
disease aggregating blood, and could explain the significant lower relative WSS in 
aggregating blood than that in non-aggregating blood as shown in Fig. 7D.  The 
insignificant difference in relative WSS between normal aggregating blood and disease 
aggregating blood might be due to that at such low pseudoshear rate,  the axial migration 
of RBC aggregates were enhanced in both aggregating conditions and the degree of cell-
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free layer formation in normal aggregating condition could be close to that in the disease 
aggregating condition. 
 
6.2 Tube diameter effect on WSS 
The present study showed that at Hct level of 40%, the relative WSS increased with 
increasing tube diameter generally probably attributed to the Fahraeus effect and 
Fahraeus-Lindqvist effect, but the extent of effects of tube diameter on WSS also 
depended on aggregating medium and pseudoshear rates.   
In non-aggregating and normal aggregating conditions, the significant difference in 
relative WSS between microtubes of ID 30µm, 50 µm and 100 µm in both high 
pseudoshear rates and low pseudoshear rates could be mainly due to the pronounced 
Fahraeus effect and Fahraeus-Lindqvist effect.  RBC aggregation in normal aggregating 
medium especially under the low venualr pseudoshear rates could cause formation of 
cell-free layer which might in turn lower the local blood viscosity.  This effect was 
reported to be more prominent in smaller microtubes [42, 47].  Thus, the reduction of 
local blood viscosity due to lower tube Hct and thicker ratio of cell-free layer in 
microtubes of smaller diameters would probably lead to the significantly lower WSS in 
smaller microtubes than that in larger microtubes as shown in Table 1. 
In disease aggregating conditions, the effect of tube diameter on WSS depended on 
the pseudoshear rates.  As discussed before, at pseudoshear rates of 200 s-1 and 80 s-1, 
RBC aggregates are broken up by high shear flow and Non-Newtonian blood behaves 
like a Newtonian fluid, and thus the significant increase in the relative WSS of blood 
suspension in microtubes from ID 30 µm to 100 µm was mainly due to the dominant 
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Fahraeus effect and Fahraeus-Lindqvist effect.  However, it was noted that the difference 
in relative WSS between tubes of ID of 30 µm and 50 µm was significant at normal 
venular pseudoshear rate of around 10 s-1, but insignificant at reduced venular 
pseudoshear rate of 3 s-1.  This could be due to that at reduced venular pseudoshear rate 
of 3 s-1, the enhanced RBC aggregation promoted the formation of the cell-free layer so 
pronouncedly that the local blood viscosity in both microtubes of ID of 30 µm and 50 µm 
would be close to the medium viscosity.  It appeared that effect of elevated RBC 
aggregation was a dominant factor to WSS over tube diameter effect at low reduced 
venular pseudoshear rates.  On the contrary, at normal venular pseudoshear rate of around 
10 s-1, the degree of cell-free layer formation might not be so prominent in microtubes of 
ID 30 µm and 50 µm.  Thus, higher local blood viscosity in microtube of ID 50 µm 
would lead to higher WSS than in microtube of ID 30 µm.  The significant difference in 
relative WSS between microtubes of ID 100 µm and 30 µm and between microtubes of 
ID 100 µm and 50 µm would be probably attributed to the dominant Fahraeus effect and 
Fahraeus-Lindqvist effect due to larger differences in tube size. 
 
6.3 Hct effect on WSS 
The present study showed that Hct exerted a prominent influence on the relative WSS.  
As shown in Table 3, high Hct of 60% led to significantly higher WSS compared to that 
at normal level of 40% and low level of 20% in all microtubes of ID 30, 50 and 100 µm 
at both high and low pseudoshear rates.  Low Hct of 20% led to significant lower WSS 
compared to that at normal Hct of 40% except in microtube of ID 30 µm in normal and 
disease aggregating medium and microtubes of ID 50 µm in disease medium at reduced 
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venular pseudoshear rate as shown in Table 3.  This finding might be due mainly to the 
elevation of local blood viscosity and decrease of cell-free layer associated with the 
increase in Hct [32, 33, 49, 57].  
The present study found that effects of Hct on the WSS also depended on the 
aggregating mediums and tube diameters.  The insignificant difference in relative WSS 
between Hct of 20% and 40% at reduced venular pseudoshear rate in microtubes of ID 30 
and 50 µm was found in aggregating mediums, but not in the non-aggregating medium as 
shown in Table 3.  One plausible explanation could be that the cell-free layer formation 
was significant in aggregating medium, but was not significant in non-aggregating blood 
even at low pseudoshear rates [50].  It appeared that at the absence of significant cell-free 
layer, Hct exerted a predominant effect on WSS.  In the aggregating conditions, the 
reduced venular pseudoshear rate facilitated the axial migration of RBC aggregates and 
the formation of the cell-free layer.  As a result, the local viscosity in both blood samples 
at 20% and 40% Hct would be close and account for the insignificant difference of 
relative WSS between 20% and 40% Hct at this reduced venular flow rate.  The result 
might also suggest that RBC aggregation effect was a predominant contributor to WSS 
over Hct at low pseudoshear rates.  However, it was noted that the WSS of blood samples 
between 20 % and 40 % Hct differed significantly in microtube of ID 100 µm, and this 
would probably be attributed to the higher tube Hct and lower degree of cell-free layer 
formation in larger tube due to the Fahraeus-effect.  This was further supported by the 
increasing ratio of the cell-free layer to the vessel diameter with decreasing vessel 
diameter [42, 57].  The above results also suggested that changes in Hct might exert a 
greater effect on WSS in larger tubes than smaller ones.   
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6.4 Threshold pseudoshear rates and WSS 
In non-aggregating medium, relative WSS increased with decreasing pseudoshear 
rates as shown in Fig. 6 and it could be probably attributed to the shear thinning of blood 
[53].  As pseudoshear rates increased, the RBCs underwent a larger degree of 
deformation and aligned themselves with blood flow direction so as to reduce the 
resistance [50].  As shear rate decreased, the degree of RBC deformation decreased and 
the cells orientated more randomly, leading to a rise in the blood viscosity.  However, the 
threshold pseudoshear rates that characterized the reversal of the trend of increasing 
relative WSS while decreasing pseudoshear rate was observed in aggregating blood.  This 
phenomenon could mainly be attributed to the effects of RBC aggregation.  The tendency 
of RBC aggregation increased with decreasing pseudoshear rate, enhancing axial 
migration of RBC towards the capillary tube core, leading to a compact RBC core at the 
center and prominent cell-free layer near the tube wall [50, 53].  The formation of the 
cell-free layer near the tube wall with the suspension medium as the main constituents 
lowered the local blood viscosity [50, 53].  Below the threshold pseudoshear rate, the 
viscosity reducing effect associated with cell-free layer became more dominant, resulting 
in the decreased WSS.  Furthermore, the threshold pseudoshear rates shifted to the higher 
values with increased RBC aggregation level, decreased Hct and decreased tube diameter 
as shown in Table 2, suggesting that the reduction in local blood viscosity and reduction 
in WSS due to the cell-free layer formation were promoted with enhanced level of RBC 
aggregation, decreased Hct and decreased tube diameter. 
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6.5 Pathophysiological implications   
The present study showed that high Hct of 60% found in polycythemia could lead to 
abnormally high WSS in all three tubes and three different mediums.  The pronounced 
elevation of WSS would probably initiate the vasodilatory mechanism by producing a 
vessel dilator, NO [1, 76].  However, the overloaded WSS could cause endothelial injury 
and intimal disease such as aneurysm and aneurysm ruptures [14-16, 99].  Furthermore, 
the thinner cell-free layer associated with higher Hct would enhance the nitric oxide NO 
scavenging effect and lower the bioavailability of NO for the flow-induced vasodilatory 
response [117-119].   
This study also presented that low Hct of 20% could generally lead to the abnormally 
low WSS.  The decrease in WSS would attenuate the production of atheroprotective NO 
from the endothelium.  NO plays a critical role in regulating smooth muscle tone and 
maintaining vascular resistance.  Thus, the decrease in NO production might lead to 
unwanted vascular constriction, resulting in the high blood pressure [92, 93].  In addition 
to its vasodilating function, NO plays important roles in vascular homeostasis through 
inhibition of platelet aggregation and formation of atherosclerotic plaques [78, 79].  
Decreased inhibition of platelet aggregation due to lack of NO bioavailability was 
reported to cause a thrombotic disorder [120].  A number of in vivo studies found that 
atherosclerosis were preferentially initiated in regions of low WSS [11-13].  Hence, 
patients suffering from abnormally low Hct may be more vulnerable to the thrombosis 
and atherosclerosis.  Shen and coworkers reported that the lower availability of NO led to 
the increase in oxygen consumption of the muscular tissues at both resting and exercise 
states [121].  Similar results were also reported in study of other tissues including kidney 
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medulla, brain and diaphragm [122-124].  On the other hand, lower Hct or number of 
RBCs would lead to reduced capacity of oxygen delivery to tissues.  The increase in the 
thickness of cell-free layer would likely hinder and reduce the oxygen delivery further.  
Hence, probably anemia patients were more vulnerable to suffer from tissue hypoxia due 
to the increase in the oxygen demand from the tissues and lower efficacy of oxygen 
delivery.  
In addition, the study shows that at the normal venular pseudoshear rate of 10 s-1, 
disease aggregating blood could lead to significantly lower relative WSS in venules, 
resulting in the reduced bioavailability of NO and increased risk of hypertensions, 
thrombosis and atherosclerosis as discussed above.  Recently Ong et al. and Namgung et 
al. reported that pseudoshear rates as low as 17.0 ± 6.4 and 9.2 ± 0.6 s-1 respectively were 
found in arterioles due to the nonuniform reduction of flow velocity by the arterial 
pressure drop [105, 113].  Hence, when arteriolar blood flow is reduced in certain disease 
states such as sepsis, ischemia-reperfusion and hemorrhage, disease level of RBC 
aggregation might lead to significantly lower WSS and cause the same diseases in 
arterioles as well.  
The venular network is characterized by the frequent branching, the continual 
infusion of RBCs and aggregates from the tributaries and small ratio of vessel length to 
diameter of 1 to 10 compared to the ratio of 100 to 1000 in vitro studies, and thus the 
shorter transit time through a given vessel segment may hinder the axial migration of 
RBC and phase separation in vivo [125], attenuating the cell-free layer formation and 
shifting the threshold pseudoshear rates to lower values.  Thus, disease aggregating blood 
might not lower the WSS significantly in pseudoshear rates found in normal venular flow, 
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but could lead to significant low WSS in reduced venular flow.  On the other hand, in the 
arteriolar network, the network Fahraeus effect as a result of a series of plasma skimming 
could probably further decrease the Hct in downstream microvessels, promoting the cell-
free layer formation and decreasing the WSS.  Thus disease level of RBC aggregation 
could not only cause significantly low WSS in reduced arteriolar flows, but perhaps also 
























CHAPTER 7  CONCLUSIONS  
 
The present study investigated the effects of two hemorheological factors RBC 
aggregation and Hct, and a geometric factor, tube diameter (tube size) on WSS.  The 
study was performed with special reference to three aggregating mediums corresponding 
to the non-aggregating blood, normal aggregating blood and disease aggregating blood 
and Hct at physiological level of 40% and clinical level of 20% and 60% in microtubes of 
ID 30 µm, 50 µm and 100 µm relevant to microcirculation.  Relative WSS (WSS of 
blood suspension normalized by the WSS of suspending medium) was used to isolate the 
medium viscosity effect on WSS.  Four typical pseudoshear rates of about  200 s-1, 80 s-1, 
10 s-1 and 3 s-1 corresponding to the normal arteriolar pseudoshear rates, reduced 
arteriolar pseudoshear rates, normal venular pseudoshear rates and reduced venular 
pseudoshear rates were of particular interests and used to investigate effects of RBC 
aggregation, Hct and tube diameter on WSS.  
The present study showed that at normal and reduced arteriolar pseudoshear rates of 
about 200 s-1 and 80 s-1, RBC aggregation was insignificant in affecting relative WSS.  
However, RBC aggregating was effective in reducing relative WSS at low venular 
pseudoshear rates of about 10 s-1 and 3 s-1 and this effect was more prominent in disease 
aggregating states.  
The present study showed that the extent of effects of tube diameter on WSS 
depended on aggregating mediums and pseudoshear rates.  In non-aggregating and 
normal aggregating conditions, the relative WSS increased significantly with increasing 
tube diameter in all investigated pseudoshear rates, probably attributed to the prominent 
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Fahraeus effect and Fahraeus-Lindqvist effect.  However, in the disease aggregating 
condition there was no significant difference in relative WSS between microtube of ID 30 
µm and 50 µm at reduced venular pseudoshear rate of about 3 s-1.  
The present study also indicated that generally the abnormally low and high Hct at 
clinical levels led to significant low or high WSS, probably due to the elevation of blood 
viscosity and reduction of cell-free layer in blood samples with higher Hct.  In addition, 
the results demonstrated that the extent of Hct effect on WSS depended on aggregating 
mediums and tube sizes.  The insignificant difference in relative WSS between Hct of 
20% and 40% at reduced venular pseudoshear rate of 3 s-1 was found in aggregating 
mediums, but not in the non-aggregating medium.  Changes in Hct were shown to exert a 
greater effect on WSS in larger tubes than smaller ones.   
The present study might indicate that at reduced venular pseudoshear rate of about 3 
s-1, RBC aggregation effect could likely be more dominant over Hct effect and tube effect 
in contributing to WSS.  On the other hand, at higher pseudoshear rates, effects of Hct 
and tube diameter could be more prominent over effects of RBC aggregation.  
Threshold pseudoshear rates characterized with the reversal of the trend of increasing 
relative WSS with decreasing pseudoshear rate were observed.  The threshold 
pseudoshear rates shifted to the higher values with increased RBC aggregation levels, 
decreased Hct and decreased tube diameter, suggesting that WSS was likely to be 
lowered by higher level of RBC aggregation, lower Hct and in smaller tubes.  
The comprehensive quantitative information on effects of RBC aggregation, Hct and 
tube diameter on WSS and pathophysiological implications of abnormally low and high 
WSS obtained from the study would facilitate an improved understanding of WSS and 
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hemorheology in the microcirculation.  This information could possibly help in 
developing novel diagnostic and therapeutic approaches to vascular diseases due to 
abnormalities in WSS. 
RBC deformability is also one of the major determinants of blood viscosity and it 
plays an important role in influencing WSS.  Hence, it will be beneficial to study effects 
of RBC deformation on WSS over the pseudoshear rate ranging from approximate 1 to 
300 s-1 in microtubes of ID 30µm, 50µm and 100µm.  The RBC deformability will be 
varied by different concentration of glutaraldehyde to mimic the various degrees of 
deformability found in clinical conditions.  Thus, a comprehensive study on effects of 
three hemorheological factors, RBC aggregation, Hct and deformability and one 
geometrical factor, tube diameter (tube size) on WSS in microtubes would be achieved.  
Microfluidic devices with various curvatures and branches mimicking microcirculation 
network could be employed to further study the role of RBC aggregation, Hct and 
deformability on WSS.  In addition, a microscope system would be included in the future 
study to measure and record the thickness of the cell-free layer.  The cell-free layer 
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APPENDIX A  DERIVATION OF WSS 
 






1. Flow is fully developed as length of tube L is much greater than tube radius R, 
L>>100R.  Thus entrance effects can be neglected. 
2. Flow is incompressible. 
3. Flow is isothermal. 
4. No external forces acts on the fluid. 
5. Radial velocity vr=0 as there are no holes in the cylinder for fluid to escape 
radially. 
6. Angular velocity vθ=0 is there are no swirls in the fluid 
7. No slip condition implies v=0 at the walls. 




ρρ                          (A.1) 











0=⋅∇ v                                        (A.2) 
Thus only an axial velocity component exists and it will be a function of tube radius only: 
vz=vz(r)                                          (A.3) 
The Navier-Stokes equation is an application of Newton's second law to a continuum and 
is then expressed as follows: 
fp
Dt
Dv +Τ⋅∇+−∇=ρ                            (A.4)                                  
where 
Dt
Dvρ  is the acceleration of the fluid; 
p∇−  is pressure gradient and arises from normal stresses; 
Τ⋅∇  is the viscous forces; for incompressible flow, this is only a shear effect; 
f represents "other" forces, such as gravity. 
Applying with the assumptions and obtained: 
Dt
Dvρ =  0                     (A.5) 
Τ⋅∇ = rzτ 2пr z                   (A.6) Δ
p∇− = пr2 (Pz+ z - Pz)                       (A.7) Δ
Substituting the above back into Navier-Stokes equation, dividing by z, and taking the 
limit as zÆ0, the following equation is obtained: 
Δ
Δ





−=−=τ                                                                                 (A.8) 
It is important to note that no assumptions have been made regarding the relationship 
between shear stress and shear rate.  Thus, Equation (A.8) holds for all fluids regardless 
of Newtonian fluid or non-Newtonian fluid. 
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Figure B1. Comparison of relative WSS of blood samples at 40% Hct in microtubes of ID 
30 µm, 50 µm and 100 µm in non-aggregating blood (A): at pseudoshear rate of about 
200 s-1; (B) at pseudoshear rate of about 80 s-1; (C) at pseudoshear rate of about 10 s-1; 
(D) at pseudoshear rate of  about 3 s-1.  Values are means ± SD.  * P < 0.05.  ** P < 0.01.  










































Figure B2. Comparison of relative WSS of blood samples at 40% Hct in microtubes of ID 
30 µm, 50 µm and 100 µm in disease aggregating blood. (A): at pseudoshear rate of 
about 200 s-1; (B) at pseudoshear rate of about 80 s-1; (C) at pseudoshear rate of about 10 
s-1; (D) at pseudoshear rate of about 3 s-1.  Values are means ± SD.  * P < 0.05.  ** P < 







Figure B3. Relative WSS of blood samples at Hct of 20% (○), 40% (∆) and 60% (□) over 
pseudoshear rates in microtube of ID 100 µm in three aggregating mediums. (A): in non-
aggregating medium; (B) in normal aggregating medium; (C): in disease aggregating 



















Figure B4. Relative WSS of blood samples at Hct of 20% (○), 40% (∆) and 60% (□) over 
pseudoshear rates in microtube of ID 30 µm in three aggregating mediums. (A): in non-
aggregating medium; (B) in normal aggregating medium; (C): in disease aggregating 
























Figure B5. Comparison of relative WSS of blood samples at Hct level of 20% VS 40% 
VS 60% in microtube of ID 100 µm at four typical pseudoshear rates observed in normal 
arteriolar flow (200 s-1)  , reduced arteriolar flow (80 s-1), normal venular flow (10 s-1)  
and reduced venular flow (3 s-1) in three aggregating mediums. (A): in non-aggregating 
medium; (B): in normal medium; (C): in disease medium. Values are means ± SD. * P < 




















Figure B6. Comparison of relative WSS of blood samples at Hct level of 20% VS 40% 
VS 60% in microtube of ID 30 µm at four typical pseudoshear rates observed in normal 
arteriolar flow (200 s-1)  , reduced arteriolar flow (80 s-1), normal venular flow (10 s-1)  
and reduced venular flow (3 s-1) in three aggregating mediums. (A): in non-aggregating 
medium; (B): in normal medium; (C): in disease medium. Values are means ± SD. * P < 
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